RNAi-mediated knockdown of aldehyde dehydrogenase class-1A1 and class-3A1 is specific and reveals that each contributes equally to the resistance against 4-hydroperoxycyclophosphamide

Cancer Chemotherapy and Pharmacology
Jan S MorebJames R Zucali

Abstract

Aldehyde dehydrogenases class-1A1 (ALDH1A1) and class-3A1 (ALDH3A1) have been associated with resistance to cyclophosphamide (CP) and its derivatives. We have previously reported the downregulation of these enzymes by all-trans retinoic acid (ATRA). In this study, we used siRNA duplexes as well as retrovirally expressed siRNA to knockdown one or both enzymes together in A549 lung cancer cell line in order to investigate the role of each one in mediating the resistance and the effect of the addition of ATRA. The results show that significant and specific knockdown of each enzyme can be achieved and that each one contributes similarly to cell resistance to 4-hydroperoxycyclophosphamide (4-HC), an active derivative of CP. Added effects were seen when both enzymes were inhibited. The addition of ATRA also exhibited additional inhibitory effects on ALDH activity and increased 4-HC toxicity when added to single siRNA aimed at one of the enzymes. On the other hand, ATRA had minimal and insignificant additional inhibitory effects on ALDH enzyme activity when added to a combination of siRNAs against both enzymes, but still increased 4-HC toxicity beyond that seen with RNAi-mediated inhibition of both enzymes together. We conclude that b...Continue Reading

References

Jan 15, 1994·Cancer Letters·U von EitzenH W Goedde
Mar 7, 1998·European Journal of Biochemistry·A YoshidaC Chang
Jan 29, 1999·Cancer Chemotherapy and Pharmacology·G P Kalemkerian, X Ou
Jan 13, 2001·Chemico-biological Interactions·V VasiliouD R Petersen
Apr 18, 2001·Chemico-biological Interactions·N A SophosV Vasiliou
Aug 29, 2001·Nature Structural Biology·P D Zamore
May 1, 2002·Nature Biotechnology·Thomas Tuschl
May 1, 2002·Nature Biotechnology·Cynthia P PaulDavid R Engelke
Mar 5, 2003·Journal of Biochemical and Molecular Toxicology·Norman E Sládek
Mar 3, 2004·Molecular Interventions·Thomas Tuschl, Arndt Borkhardt
Oct 8, 2004·The Journal of Pharmacology and Experimental Therapeutics·Jan S MorebDagmara Mohuczy
Dec 30, 2004·Investigative Ophthalmology & Visual Science·Sanjeev ChoudharyNaseem H Ansari
Mar 17, 2005·JAMA : the Journal of the American Medical Association·Premlata ShankarJudy Lieberman
May 21, 2005·The Journal of Biological Chemistry·Aglaia PappaVasilis Vasiliou

❮ Previous
Next ❯

Citations

Jun 8, 2011·Clinical & Experimental Metastasis·Christel van den HoogenGabri van der Pluijm
Oct 25, 2011·The Journal of Biological Chemistry·May KhannaThomas D Hurley
Aug 19, 2010·Molecular Cancer Therapeutics·Stephen B Keysar, Antonio Jimeno
Jan 5, 2011·Frontiers in Bioscience (Landmark Edition)·Matthew A Sanders, Adhip P N Majumdar
Nov 28, 2013·Virchows Archiv : an International Journal of Pathology·Julien CalderaroJessica Zucman-Rossi
Apr 26, 2014·British Journal of Cancer·J YanD Tang
Jul 10, 2008·Expert Opinion on Drug Metabolism & Toxicology·Satori A MarchittiVasilis Vasiliou
Oct 28, 2008·Chemico-biological Interactions·Deniz UcarJan S Moreb
Feb 22, 2017·Journal of Medicinal Chemistry·Cameron D Buchman, Thomas D Hurley
Dec 13, 2016·Cancer Chemotherapy and Pharmacology·Jan S MorebAbdullah Khan
Jan 7, 2017·International Journal of Biological Macromolecules·Amaj Ahmed LaskarHina Younus
Jul 28, 2009·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Joanna GiebułtowiczJacek Wierzchowski
Jan 1, 2011·Cancers·Ulrike OlszewskiGerhard Hamilton
Dec 2, 2017·International Journal of Molecular Sciences·Marta Prieto-VilaTakahiro Ochiya
Jan 6, 2018·International Journal of Molecular Sciences·Petr ChlapekRenata Veselska
Nov 6, 2018·Immunology·Christopher G BazewiczGavin P Robertson
Feb 11, 2018·Scientific Reports·Peter Mu-Hsin ChangChi-Ying F Huang
Sep 18, 2010·The Journal of Pathology·Malcolm R AlisonLinda J Nicholson
Feb 16, 2012·Angewandte Chemie·Tanja WirthStephan A Sieber
Jan 28, 2020·Chembiochem : a European Journal of Chemical Biology·Sebastiaan T A KoendersMario van der Stelt
Mar 29, 2014·Chembiochem : a European Journal of Chemical Biology·Bibek ParajuliThomas D Hurley
Aug 27, 2016·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Peyman RanjiAli Mohammad Alizadeh
Oct 5, 2018·Cell and Tissue Research·Kanji HirashimaKatsunori Sasaki
Feb 9, 2019·Stem Cells International·Giuseppe Vassalli
Oct 17, 2019·Cancers·Jung-A ChoiJae-Hoon Kim

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.